NOVEL IL-4-/IL-13-DERIVED PEPTIDE COMPOUNDS FOR THE TREATMENT OR PREVENTION OF NEURODEGENERATIVE OR NEUROINFLAMMATORY DISEASES
Download Read
Applicant
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Representative
Schwertfeger Partnerschaft mbB Patentanwälte Dr. Keller
Application number
EP18158758A1
Kind
A1
Document number
3530320
Shortcuts
→Abstract
→Claims
→References by patents

Classifications

NOVEL IL-4-/IL-13-DERIVED PEPTIDE COMPOUNDS FOR THE TREATMENT OR PREVENTION OF NEURODEGENERATIVE OR NEUROINFLAMMATORY DISEASES

3530320 - EP18158758A1 - EPO

Application Feb 27, 2018 - Publication Aug 28, 2019

Christina Francisca VOGELAAR Frauke ZIPP

Abstract

The present invention relates to A compound consisting of one or more peptides comprising the structureA - L1 - B - L2 - CwhereinA corresponds to a first amino acid sequence that is derived from αA or αC alpha helical region of human or animal IL-4 or IL-13,B corresponds to a second amino acid sequence that is derived from αA or αC alpha helical region of human or animal IL-4 or IL-13,C corresponds to a third amino acid sequence that is derived from αD or aB alpha helical region of human or animal IL-4, or αD alpha helical region of human or animal IL-13.L1 and L2 correspond to one or more linking amino acids.

Description

Claims

Patent References

Patent Publication Date Title
9082158 16/03/1999 Strain of gypsy moth virus with enhanced polyhedra and budded virus production
EP09764175A1 21/09/2011 IL-4-DERIVED PEPTIDES FOR MODULATION OF THE CHRONIC INFLAMMATORY RESPONSE AND TREATMENT OF AUTOIMMUNE DISEASES
Back to top

Statistics

Seen <100 times
Downloaded <100 times